Evidence map›Paper›PMID 40042303›Full record

ArticleMicrobiology spectrum2025

A high-throughput anaerobic method for viability assays.

Mohamed El-Fateh, Christian T Meyer, Anushree Chatterjee, Xin Zhao

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohamed El-FatehDepartment of Animal Science, McGill University, Sainte-Anne-de-Bellevue, Quebec, Canada.ORCID 0000-0003-0301-2771
Christian T MeyerAntimicrobial Regeneration Consortium (ARC) Labs, Louisville, Colorado, USA.ORCID 0000-0002-8719-6522
Anushree ChatterjeeAntimicrobial Regeneration Consortium (ARC) Labs, Louisville, Colorado, USA.ORCID 0000-0002-8389-9917
Xin ZhaoDepartment of Animal Science, McGill University, Sainte-Anne-de-Bellevue, Quebec, Canada.ORCID 0000-0002-1078-7332

Funding

The electrophysiology of biofilm development and drug resistanceK99AI175656 · NIAID · UNIVERSITY OF COLORADO · PI MEYER, CHRISTIAN T · 2023 to 2024
$277k
Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC) ALLRP-588882-23Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC) RGPIN-2022-03884FRQ | Fonds de recherche du Québec - Nature et technologies (FRQNT) 2023-2024 - B2X - 332869HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) 1K99AI175656Mitacs (Mitacs Canada) IT28634NIAID NIH HHS K99 AI175656
6 · The paper itself

Abstract

Viability testing for anaerobes is a time-consuming and expensive process, posing challenges for research and public health settings. Here, we present a rapid, economical, and reliable method for testing anaerobe viability using the Geometric Viability Assay (GVA) with IMPORTANCE: The routine assessment for the viability of anaerobes is based on bacterial plating, but so far, it has been limited in throughput by the long preparation steps and the tedious anaerobic culturing. Thus, comparatively little is known about the susceptibility pattern, and the sporulation of anaerobes because of the absence of the proper method. Here, we show GVA can quantify the anaerobic

Indexed as

Anti-Bacterial AgentsBacteria, AnaerobicClostridium perfringensHigh-Throughput Screening AssaysMicrobial ViabilityAnaerobiosisClostridium InfectionsHumansMicrobial Sensitivity TestsAnti-Bacterial Agentsanaerobesantibiotic resistancebacterial viabilitybactericidal activitysporessusceptibility testing

Identifiers

PMID40042303
PMCPMC11960071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.